A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate progression-free survival in participants with
gastric or gastroesophageal junction cancer who have had disease progression following
first-line therapy who undergo treatment with ramucirumab.